achromatopsia gene therapy
Page 1 of 1
achromatopsia gene therapy
Creative Biolabs provides comprehensive gene therapy technologies and services to improve the symptoms of achromatopsia. achromatopsia gene therapy
Re: achromatopsia gene therapy
Introducing new genetic material into target cells without causing toxicity to non-target tissues is the goal of cancer gene therapy. The adeno-associated virus (AAV) is a small virus that allows packaging of only 4 kb inserts. AAV has low toxicity, apparent lack of pathogenicity and provides long-term transgene expression through chromosomal integration. Using the basic principles of molecular biology and laboratory techniques, Creative Biolabs provides a wide variety of AAV vectors for both basic research and clinical applications. AAV vector production service
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum